Abstract:We previously demonstrated that in the mouse only two Y chromosome genes are required for a male to produce an offspring with the help of assisted reproduction technologies (ART): testis determinant Sry and spermatogonial proliferation factor Eif2s3y. Subsequently, we have shown that the function of these genes can be replaced by transgenic overexpression of their homologs, autosomally encoded Sox9 and X-chromosome encoded Eif2s3x. Males with Y chromosome contribution limited to two (XEif2s3yOSry), one (XEif2s3yOSox9 and XOSry,Eif2s3x), and no genes (XOSox9,Eif2s3x) produced haploid germ cells and sired offspring after ART. However, despite successful assisted reproductive outcome, they had smaller testes and displayed abnormal development of the seminiferous epithelium and testicular interstitium. Here we explored whether these testicular defects originated from altered pro-testis and pro-ovary factor signaling in genital ridges at the time of sex determination. Timed pregnancies were generated to obtain transgenic XEif2s3yOSry, XEif2s3yOSox9, XOSry,Eif2s3x, XOSox9,Eif2s3x, and wild-type XX and XY fetuses at 12.5 days post coitum. Dissected genital ridges were assessed for their morphology and anatomy, and expression of pro-testis and pro-ovary transcripts. All transgenic males displayed incomplete masculinization of gonadal shape, impaired development of testicular cords and gonadal vasculature, and decreased expression of factors promoting male pathway. Fetal gonad masculinization was more effective when sex determination was driven by the Sry transgene, in the presence of Y chromosome genes, and to a lesser extent a double dosage of X genes. The study adds to the understanding of the role of Y chromosome genes and their homologs during sex determination.

CRISPR/Cas9 mediated Y-chromosome elimination affects human cells transcriptome

Distinct Expression of Mir-378 in Nonsyndromic Cleft Lip And/or Cleft Palate: A Cogitation of Skewed Sex Ratio in Prevalence

Consequences of Y chromosome microdeletions beyond male infertility

Y Chromosome Loss and Implications for Oncology

Selective loss of Y chromosomes in lung adenocarcinoma modulates the tumor immune environment through cancer/testis antigens

Abstract IA005: Y chromosome loss in cancer drives growth by evasion of adaptive immunity

Loss of Y chromosome: An emerging next-generation biomarker for disease prediction and early detection?

Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives

Mosaic Loss of Human Y Chromosome: What, How and Why

The human Y and inactive X chromosomes similarly modulate autosomal gene expression

Deletion in the Y chromosome of B10.BR-Ydel mice alters transcription from MSYq genes and has moderate effect on DNA methylation

Influence of gonadal and chromosomal sex on the brain transcriptome in a mouse species with natural sex reversal

Spermatogenic failure and the Y chromosome

Loss of chromosome Y in regulatory T cells

Post-transcriptional cross- and auto-regulation buffer expression of the human RNA helicases DDX3X and DDX3Y

Alterations of sex determination pathways in the genital ridges of males with limited Y chromosome genes†

Mosaic loss of the Y chromosome in human neurodegenerative and oncological diseases

Structural variation of the human genome: Mechanisms, assays, and role in male infertility

Systematic identification of Y-chromosome gene functions in mouse spermatogenesis

Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell types